TrialLancet (London, England)2009

Sequential docetaxel as adjuvant chemotherapy for early breast cancer (TACT): an open-label, phase III, randomised controlled trial.

Paul Ellis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.